CORC

在结果中检索

CORC

浏览/检索结果: 共92条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Landmark-RxR: Solving Vision-and-Language Navigation with Fine-Grained Alignment Supervision 会议论文
线上, 2021-12-7至2021-12-10
作者:  Keji He;  Yan Huang;  Qi Wu;  Jianhua Yang;  Dong An
收藏  |  浏览/下载：0/0  |  提交时间：2024/06/26
Neighbor-view Enhanced Model for Vision and Language Navigation 会议论文
Chengdu, China, 2021-10-20
作者:  Dong An;  Yuankai Qi;  Yan Huang;  Qi Wu;  Liang Wang
收藏  |  浏览/下载：0/0  |  提交时间：2024/05/28
Fully Automatic Dual-Guidewire Segmentation for Coronary Bifurcation Lesion 会议论文
Budapest, Hungary, 2019.07.14-19
作者:  Zhou, Yan-Jie;  Xie, Xiao-Liang;  Bian, Gui-Bin;  Hou, Zeng-Guang;  Wu, Yu-Dong
收藏  |  浏览/下载：4/0  |  提交时间：2022/06/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Functionalized MIL-68(In) for the photocatalytic treatment of Cr(VI)-containing simulation wastewater: Electronic effects of ligand substitution 会议论文
作者:  Liang, Ruowen;  Huang, Renkun;  Wang, Xuxu;  Ying, Shaoming;  Yan, Guiyang
收藏  |  浏览/下载：6/0  |  提交时间：2019/11/21
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
Simulation analysis on lubrication performance of water-lubricated elastic supported tilting pad thrust bearing 会议论文
作者:  Ning, Changxiong;  Liang, Xingxin;  Ouyang, Wu;  Yan, Xinping
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
A method for measuring film thickness of water lubricated tilting pad thrust bearings 会议论文
作者:  Liang, Xingxin;  Yan, Xinping;  Ouyang, Wu
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace